Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

A Double Blind Randomized Control Trial of Tadalafil in Interstitial Lung Disease of Scleroderma

NCT01553981 is registered in ClinicalTrials.gov with Sanjay Gandhi Postgraduate Institute of Medical Sciences as lead sponsor.

NCT NCT01553981
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT01553981 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
A Double Blind Randomized Control Trial of Tadalafil in Interstitial Lung Disease of Scleroderma
Lead sponsor
Sanjay Gandhi Postgraduate Institute of Medical Sciences
Phase
Phase 3
Overall status
Completed
Start date
March 31, 2012
Completion date
May 31, 2014
Enrollment
40 (actual)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

lung diseases, interstitial